Adi Pharmaceutical: Jiangsu Eddy Pharmaceutical Group Co., Ltd. Related Transactions Implementation Rules (Revised in September 2025)SZSI · 30 Sep 2026
BofA Securities Maintains Analog Devices(ADI.US) With Buy RatingMarket news · 15 Sep 2026
4: ADI Global Distribution | 4: Statement of changes in beneficial ownership of securities-Director RESIDEO TECHNOLOGIES, INC.SEC · 6 Aug 2026
3: ADI Global Distribution | 3: Initial statement of beneficial ownership of securities- CD&R Investment Associates XII, Ltd.SEC · 5 Aug 2026
Baird Maintains Analog Devices(ADI.US) With Buy Rating, Raises Target Price to $675Market news · 24 Aug 2026
Needham Maintains Analog Devices(ADI.US) With Buy Rating, Raises Target Price to $450Market news · 21 Aug 2026
A Quick Look at Today's Ratings for Analog Devices(ADI.US), With a Forecast Between $405 to $500Market news · 21 Aug 2026
Analog Devices (ADI.US) Q3 Earnings Call: AI Evolution Drives New Growth Cycle; “From Grid to Chip” Strategy Shapes Promising OutlookZhitong Finance · 20 Aug 2026
Cantor Fitzgerald Maintains Analog Devices(ADI.US) With Buy Rating, Maintains Target Price $550Market news · 17 Aug 2026
3: ADI Global Distribution | 3: Initial statement of beneficial ownership of securities- RESIDEO TECHNOLOGIES, INC.SEC · 8 Jul 2026
Announcement on adjusting the conversion price of "Adi Convertible Bonds" based on the 2023 profit distribution plan.SZSI · 4 Jul 2026
Adi Pharmaceutical: Jiangsu Eddy Pharmaceutical Co., Ltd. Related Transactions Implementation Rules (Revised in October 2024)SZSI · 31 Oct 2026